COMPANY PROFILE

EnClear Therapies

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

Newburyport, United StatesFounded 2018Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2020

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About EnClear Therapies

EnClear Therapies is a biotechnology company focused on improving and extending the lives of patients with central nervous system (CNS) diseases through precision dosing. The company operates in the neuro-oncology and neurodegenerative disease markets, leveraging its proprietary EnTrega CSF Platform for controlled, continuous, and personalized delivery of therapeutics. EnClear Therapies serves patients with conditions such as Leptomeningeal Carcinomatosis and aims to expand into neurodegenerative, lysosomal storage, and autoimmune diseases through strategic partnerships. The business model involves developing and commercializing a pipeline of patient-focused opportunities, generating revenue through the sale and licensing of its therapeutic solutions. The company brings together a multidisciplinary team with a proven track record in biomedical technology and market development.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Newburyport, United States
Employees: 8
Open positions: None listed
Dealroom signal: 59.5/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning EnClear Therapies.

See all news

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Sep 2024	$0	—	Thiel Capital · Tachyon Valley BioLabs · Bioverge · Sontag foundation	↗
SERIES A✓Equity / VC	Feb 2020	$10M	$40M	Amgen Ventures · Global Health Science Fund · Thiel Capital · Presight Capital	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

EnClear Therapies website traffic

Latest recorded traffic for EnClear Therapies is 90 monthly website visits, down 91.8% over the last three months. EnClear Therapies's team declined 11.1% over the past year.

Latest monthly visits90 3-month web change-91.8% 1-year team growth-11.1%

Monthly website visitsMay 2018–Dec 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ELElectroCoreHelping patients across the globe who suffer from pain and chronic conditions by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments	Rockaway Township, United States	Operational	69	$135M	$87M
ACAccexibleDeveloping a speech analysis platform based on AI models to early detect diseases as dementia, Parkinson, and coronary disease	Bilbao, Spain	Operational
NMNeuSpera MedicalNeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called â€œelectroceuticals	San Jose, United States	Operational
ODOptina DiagnosticsTechnology for the early detection of disease through the eye	Montreal, Canada	Operational
SCScribensDevelopment of non-invasive tools for early detection and follow-up of neurological dysfunctions	Montreal, Canada	Closed
MPMetys PharmaceuticalsDeveloping dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy	Basel, Switzerland	Acquired
KEKernelNeuroscience as a Service enables on-demand access to the world's most advanced brain recording technology	Culver City, United States	Operational
UMUroDev MedicalDeveloping the Connected Catheter, the world's first fully-internal, smart catheter for bladder management	San Clemente, United States	Operational